Proton pump inhibitors are associated with increased risk of development of chronic kidney disease

被引：0
作者：
Pradeep Arora
Anu Gupta
Mojgan Golzy
Nilang Patel
Randolph L. Carter
Kabir Jalal
James W. Lohr
机构：
[1] University at Buffalo,Department of Medicine
[2] Division of Nephrology at VA Medical Center,Department of Biostatistics
[3] University at Buffalo,Department of Medicine
[4] Virginia Commonwealth University,undefined
来源：
BMC Nephrology | / 17卷
关键词：
Chronic kidney disease; Death; Outcomes; Proton pump inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Proton Pump Inhibitors and Kidney Disease-GI Upset for the Nephrologist?
    Toth-Manikowski, Stephanie M.
    Grams, Morgan E.
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (03): : 297 - 301
  • [22] Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study
    Liabeuf, Sophie
    Lambert, Oriane
    Metzger, Marie
    Hamroun, Aghiles
    Laville, Maurice
    Laville, Solene M.
    Frimat, Luc
    Pecoits-Filho, Roberto
    Fouque, Denis
    Massy, Ziad A.
    Jacquelinet, Christian
    Stengel, Benedicte
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (07) : 2967 - 2976
  • [23] Proton pump inhibitors and the kidney: critical review
    Brewster, U. C.
    Perazella, M. A.
    CLINICAL NEPHROLOGY, 2007, 68 (02) : 65 - 72
  • [24] Proton pump inhibitors, adverse events and increased risk of mortality
    Lanas-Gimeno, Aitor
    Hijos, Gonzalo
    Lanas, Angel
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (11) : 1043 - 1053
  • [25] Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
    El Chamieh, Carolla
    Larabi, Islam Amine
    Laville, Solene M.
    Jacquelinet, Christian
    Combe, Christian
    Fouque, Denis
    Laville, Maurice
    Frimat, Luc
    Pecoits-Filho, Roberto
    Lange, Celine
    Stengel, Benedicte
    De Pinho, Natalia Alencar
    Alvarez, Jean-Claude
    Massy, Ziad A.
    Liabeuf, Sophie
    TOXINS, 2023, 15 (04)
  • [26] Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort
    dos Santos, Andreza Soares
    de Menezes, Sara Teles
    Silva, Isabella Ribeiro
    Oliveira, William Neves
    Pereira, Mariana Linhares
    Mill, Jose Geraldo
    Barreto, Sandhi Maria
    Figueiredo, Roberta Carvalho
    BMC NEPHROLOGY, 2023, 24 (01)
  • [27] Proton pump inhibitors and chronic kidney disease: Reevaluating the evidence from a randomized controlled trial
    Gerstman, B. Burt
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (01) : 4 - 8
  • [28] Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system
    Wu, Bin
    Li, Dan
    Xu, Ting
    Luo, Min
    He, Zhiyao
    Li, Yuwen
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [29] Proton-pump Inhibitors and Chronic Kidney Disease: Hidden Consequences of an Inappropriate Drug Use?
    Schiffl, Helmut
    Al-Nemnem, Emad
    Lang, Susanne M.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2020, 31 (02) : 312 - 319
  • [30] Increased cardiovascular risk in patients with chronic kidney disease
    Vondenhoff, Sonja
    Schunk, Stefan J.
    Noels, Heidi
    HERZ, 2024, : 95 - 104
12345